Download

Download Full Text (459 KB)

Contents

  • Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
  • INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
  • Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
  • Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
  • HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening

Publication Date

3-1-2018

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Gomez, Daniel; Heymach, John; Swisher, Stephen G.; Neelapu, Sattva; Arthur, Joseph; Edwards, Tonya; Reddy, Suresh; Torres, Harrys; Sturgis, Erich M.; Hwang, Jessica; Hawk, Ernest T.; Joy, Manju; Rodriguez, EdenMae; Clinical Trials as Topic; Carcinoma, Non-Small-Cell Lung -- secondary; Immunotherapy; osimertinib; Antineoplastic Agents; ErbB Receptors; Surgical Procedures, Operative; Radiotherapy; Plasmablastic Lymphoma; Immunotherapy, Adoptive; Antigens, CD19; Neoplasms; Cancer Pain; Opioid-Related Disorders; Analgesics, Opioid; Naloxone; Benzodiazepines; Head and Neck Neoplasms; Hepacivirus; Early Detection of Cancer; Risk Factors.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 63. Number 03, March 2018

Share

COinS